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Little is known about molecular recognition of
acetylated N termini, despite prevalence of this
modification among eukaryotic cytosolic proteins.
We report that the family of human DCN-like
(DCNL) co-E3s, which promote ligation of the ubiqui-
tin-like protein NEDD8 to cullin targets, recognizes
acetylated N termini of the E2 enzymes UBC12 and
UBE2F. Systematic biochemical and biophysical
analyses reveal 40- and 10-fold variations in affinities
among different DCNL-cullin and DCNL-E2 com-
plexes, contributing to varying efficiencies of dif-
ferent NEDD8 ligation cascades. Structures of
DCNL2 and DCNL3 complexes with N-terminally
acetylated peptides from UBC12 and UBE2F illumi-
nate a common mechanism by which DCNL proteins
recognize N-terminally acetylated E2s and how
selectivity for interactions dependent on N-acetyl-
methionine are established through side chains
recognizing distal residues. Distinct preferences of
UBC12 and UBE2F peptides for inhibiting different
DCNLs, including the oncogenic DCNL1 protein,
suggest it may be possible to develop small mole-
cules blocking specific N-acetyl-methionine-depen-
dent protein interactions.
INTRODUCTION
Approximately 50%–90% of eukaryotic cytosolic proteins are
cotranslationally N-terminally acetylated either on Met or the
resultant N terminus following processing by Met aminopepti-
dase (Arnesen, 2011; Kalvik and Arnesen, 2012). Important func-
tions for N-terminal acetylation can be inferred from genetic
experiments in which N-terminal acetyltransferase enzymes
were deleted from budding yeast either alone or in synthetic42 Structure 21, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rightslethal screens or were knocked down in mammalian cells
(reviewed in Arnesen, 2011; Starheim et al., 2012). Nonetheless,
only a few specific functions of N-terminal acetylation have been
reported. Examples include roles of N-terminal Met acetylation in
tropomyosin-actin complex formation (Coulton et al., 2010;
Polevoda et al., 2003; Singer and Shaw, 2003) and in trafficking
of certain GTPases (Behnia et al., 2004; Setty et al., 2004). At this
point, little is known about potential regulation of and by
N-terminal acetylation. However, metabolic changes mediated
by expression of the antiapoptotic Bcl-2 family member Bcl-xL
influence the extent of cellular protein N-terminal acetylation
(Yi et al., 2011). Bcl-xL expression modulates levels of acetyl-
CoA, which provides the acetyl group to be transferred to N
termini. Notably, decreased N-terminal acetylation upon Bcl-xL
overexpression is thought to play a role in apoptotic resistance
(Yi et al., 2011). Although there are presently no known
N-terminal deacetylases, N-terminal acetylation can serve to
target proteins as substrates for ubiquitination by the yeast
ubiquitin E3 ligase Doa10, thereby directing some N-terminally
acetylated proteins for proteasomal degradation (Hwang et al.,
2010). Protein-protein interactions that sequester acetylated N
termini have been proposed potentially to protect N-terminally
acetylated proteins fromDoa10-dependent degradation (Hwang
et al., 2010; Zhang et al., 2010). Nonetheless, detailed structural
mechanisms by which N-terminal acetylation can influence
protein activities are largely unknown.
Recently, N-terminal Met acetylation was shown to be critical
for a specific protein-protein interaction that enhances ligation of
the ubiquitin-like protein (UBL), NEDD8, to a Lys in theWHB sub-
domain of the CUL1 C-terminal domain (CTD) (Scott et al., 2011).
Like other UBLs, NEDD8 is ligated by distinctive E1-E2-E3
cascades. N-terminal acetylation of the E2, UBC12, was shown
to play a role in NEDD8 ligation via a ‘‘dual E3’’ mechanism (Scott
et al., 2010, 2011). One E3, RBX1, acts as a conventional
RING ligase: RBX1’s b strand recruits the CUL1 substrate,
and RBX1’s RING domain binds the labile thioester-linked
UBC12NEDD8 intermediate and promotes NEDD8 ligation
(Scott et al., 2010). However, the linker between RBX1’s CUL1
binding site and UBC12-binding RING domain is flexible. Thereserved
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or DCNL1 in human cells, which binds other CUL1 and
UBC12 surfaces to juxtapose UBC12’s active site and CUL1’s
acceptor Lys for the NEDD8 ligation reaction. Whereas RBX1-
mediated NEDD8 ligation is independent of the state of
UBC12’s N terminus, N-terminal acetylation contributes two
orders of magnitude to the Kd for UBC12 binding to the Dcn1/
DCNL1 PONY domain (‘‘Potentiation of Neddylation,’’ also
referred to with a ‘‘P’’ superscript, e.g., DCNL1P) (Scott et al.,
2011). Crystal structures of both yeast and human Dcn1P/
DCNL1P complexes with N-terminally acetylated UBC12 pep-
tides revealed that interactions are dominated by burial of
UBC12’s N-acetyl-Met in a deep hydrophobic pocket in Dcn1/
DCNL1 (Scott et al., 2011).
Lower eukaryotes, such as budding yeast, have only one
NEDD8 E2 (Ubc12), one RBX protein (Rbx1, also called Hrt1),
and one Dcn co-E3 (Dcn1). However, typical human cells
express two NEDD8 E2s (UBC12 and UBE2F), two RBX proteins
(RBX1 and RBX2), five distinct Dcn-like proteins (DCNL 1-5),
and numerous cullins (Huang et al., 2009; Kamura et al., 1999;
Kipreos et al., 1996; Kurz et al., 2005; Ohta et al., 1999; Seol
et al., 1999; Skowyra et al., 1999; Tan et al., 1999). For the
best-studied mammalian cullins (CUL1, CUL2, CUL3, CUL4A
and B, and CUL5), NEDD8 ligation from the two different
E2s involves particular pairings with a cullin’s associated RBX
protein: UBC12 is specific for RBX1 and mediates neddylation
of RBX1-associated CUL1, 2, 3, and 4. RBX2 is specific for
UBE2F, which mediates neddylation of the RBX2 partner,
CUL5 (Huang et al., 2009). However, other than the interaction
between DCNL1P and N-terminally acetylated UBC12, the
extent to which the different DCNL PONY domains can stimu-
late cullin neddylation by the different NEDD8 E2s, and roles
of E2 N-terminal acetylation in this process, have not been
explored. This is of interest because cullin-RBX complexes
assemble with other subunits to form the largest family of ubiq-
uitin E3s, the cullin-RING ligases (CRLs), with 300 CRLs en-
coded by the human genome (Deshaies and Joazeiro, 2009).
NEDD8 ligation favors an active conformation for CRL ubiquitin
ligase catalytic activity and is estimated to elicit 20% of all 26S
proteasomal degradation (Bennett et al., 2010; Duda et al.,
2008; Saha and Deshaies, 2008; Soucy et al., 2009; Yamoah
et al., 2008).
To gain insights into structural mechanisms underlying
NEDD8 ligation by mammalian enzymes, we performed sys-
tematic biochemical, biophysical, and crystallographic anal-
yses of human CUL-DCNL-E2 interactions using purified
recombinant proteins. Our data provide a biophysical rationale
for previously described in vivo promiscuity between DCNL
and cullin components of human NEDD8 cascades (Bennett
et al., 2010; Huang et al., 2011; Kim et al., 2008; Kurz et al.,
2008; Meyer-Schaller et al., 2009) and reveal that N-terminal
acetylation of NEDD8 E2s is generally important for DCNL
activation of NEDD8 ligation to cullins. The data also show
how selectivity for protein-protein interactions dependent on
Met N-terminal acetylation can be established by subtle
differences in recognition of downstream residues among
highly homologous structures and indicate that it may be
possible to inhibit specific protein interactions mediated by
N-acetyl-Met.Structure 21RESULTS
N-terminal Acetylation of Human UBE2F Expressed
in Eukaryotic Cells
To investigate the modification status of UBE2F’s N terminus
expressed in eukaryotic systems, we purified C-terminally
tagged forms of the protein. In NIH 3T3 cells, we retrovirally
expressed human UBE2F harboring a C-terminal His6 and
FLAG-tag (Huang et al., 2009). Following anti-FLAG immunopre-
cipitation, liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis revealed UBE2F as retaining its N-terminal
methionine and being N-terminally acetylated (Figure 1A). Similar
results were obtained for C-terminally His-tagged UBE2F
purified after baculovirus-mediated expression in insect cells
(Figure 1B; Figure S1A available online). N-terminally acetylated
UBE2F is referred to hereafter as UBE2FNAc.
DCNL PONY Domains Can Potentiate NEDD8 Ligation
from N-terminally Acetylated UBE2F
Can N-terminally acetylated UBE2F mediate NEDD8 ligation? In
the absence of DCNL1, RBX1 can promote efficient NEDD8
transfer from UBE2F to an associated CUL1 C-terminal domain,
and RBX2 can promote efficient NEDD8 transfer from UBE2F to
an associated CUL5 C-terminal domain (Huang et al., 2009). To
assess potential roles of UBE2F N-terminal acetylation, we
compared activities of UBE2FNAc with unacetylated UBE2F
prepared in Escherichia coli as a SUMO fusion protein (Mosses-
sova and Lima, 2000), which yields an unacetylated N-terminal
Met after cleavage with the protease SENP2 (Figure S1B). Using
a pulse-chase assay, we exclusively examined NEDD8 transfer
from the E2s to cullin targets (Figures 1C and 1D). Briefly, after
E1-mediated ‘‘pulse’’ generation of a thioester-linked E2[32P]-
NEDD8 intermediate, a cullin CTD-RBX complex was added,
and radiolabeled NEDD8 was ‘‘chased’’ from the E2 to the cullin.
In the absence of a DCNL, NEDD8 transfer to the CUL1 or CUL5
CTDs in complex with RBX1 or RBX2, respectively, is insensitive
to whether or not UBE2F is N-terminally acetylated, and there
was no effect of any DCNL PONY domain on NEDD8 transfer
from unacetylated UBE2F (Figure 1C). However, under the
conditions of our assays, the PONY domains from all five
DCNL family members potently stimulated NEDD8 transfer
from UBE2FNAc to RBX2-associated CUL5CTD, and PONY
domains fromDCNLs 1-3 also clearly stimulated NEDD8 transfer
from UBE2FNAc to RBX1-associated CUL1CTD (Figure 1D).
DCNL-CUL and DCNL-NEDD8 E2 Interactions
Contribute to Specificity of NEDD8 Ligation Pathways
In Vitro
To gain insights into the extent of DCNL activity toward the
different cullins and NEDD8 E2s, we systematically character-
ized DCNL PONY domain interactions. First, we focused on
DCNL-cullin complexes. Previous studies localized interactions
to the PONY domain from DCNL1 and the WHB subdomain of
CUL1 (Kim et al., 2008; Kurz et al., 2008; Scott et al., 2010,
2011). Thus, we focused on these regions, which are conserved
among all human family members (Figure S2) (Kim et al., 2008;
Kurz et al., 2008). All 30 pairwise combinations of the five
DCNL PONY domains and six cullin WHB subdomains showed
interactions by isothermal titration calorimetry (ITC), albeit with, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 43
Figure 1. Role of N-terminal Acetylation of the NEDD8 E2 UBE2F in Human DCNL PONY Domain-Stimulated NEDD8 Ligation
(A) MS/MS spectrum resulting from the N-terminal peptide after Arg-C digestion/desalting of human UBE2F expressed in NIH 3T3 cells following affinity puri-
fication via a C-terminal tag. The corresponding XCorr and DCN values are indicated as well as the y (red) and b (blue) ions used to match the peptide sequence.
(B) MS/MS spectrum of the N-terminal peptide from Arg-C digested UBE2F-His purified from insect cells upon baculovirus-mediated expression.
(C) Pulse-chase [32P]NEDD8 transfer from unacetylated UBE2F to either CUL1CTD-RBX1 (labeled CUL1C-RBX1) or CUL5CTD-RBX2 (labeled CUL5C-RBX2) in
the absence or presence of the indicated DCNL PONY domain.
(D) Pulse-chase [32P]NEDD8 transfer assays as in (C), except with the N-terminally acetylated E2 UBE2FNAc.
See also Figure S1.
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range in Kd values appears largely dictated by the identity
of the cullin, rather than by the DCNL family member. As exam-
ples, the PONY domains from all five DCNL family members bind
to the WHB subdomains from CUL2, CUL3, and CUL5 with Kd
values in the submicromolar range, whereas interactions with
the CUL1, CUL4A, and CUL4B WHB subdomains displayed Kd
values in the micromolar range. Indeed, the WHB subdomain
from CUL5 binds tightly to all the different PONY domains with
only a 3-fold range in Kd (0.05–0.15 mM), and the WHB subdo-
main from CUL1 binds much more weakly to all the different
PONY domains with only a 2-fold range in Kd (0.99–2.0 mM).
Sequence alignments in light of a prior DCNL1P-CUL1WHB
crystal structure (Scott et al., 2010, 2011) explain this promis-
cuity, as key interacting residues are conserved in all five
DCNL PONY domains and the various cullin WHB subdomains
(Kim et al., 2008; Kurz et al., 2008). However, the assorted amino
acid variations that are spread throughout the interaction surface
likely account for differences in affinities (Figure S2). Some differ-
ences are observed in a docking model in which the CUL5WHB
structure (Duda et al., 2008) is superimposed onto CUL1WHB
from the complex with DCNL1P (Scott et al., 2011) (Figure 2B).
Among the DCNL-interacting residues least conserved among
the cullins are Val746 in CUL1/Lys750 in CUL5, and Lys769 in
CUL1/Ile773 in CUL5 (Figure S2). These may contribute to the
more favorable interactions for CUL5, where Lys750 would be
predicted to form a salt bridge with DCNL1 Glu233, which is
conserved as Glu or Asp among all five DCNLs, and Ile773 would44 Structure 21, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rightsbe predicted to pack against a conserved DCNL Trp side chain
(Figure 2B).
We also performed ITC experiments to examine interactions
between the different DCNL PONY domains with the NEDD8
E2s (Figures 2C and S2). Because of challenges with producing
the large amounts of UBC12NAc in insect cells required for ITC,
we examined interactions between the different DCNL PONY
domains with a 21-residue peptide corresponding to the
N-terminal helix of UBC12NAc (Figure 2C). The Kd values of
2 mM obtained for DCNL1P and DCNL2P binding to this
UBC12 peptide are similar to those reported previously for
DCNL1P binding to full-length UBC12NAc or to an acetylated
N-terminal 26-residue peptide (Scott et al., 2011). However,
there was striking variation in affinities, with 5- to 10-fold higher
Kd values for interactions between the N-terminally acetylated
UBC12 peptide and PONY domains from DCNL3, DCNL4, or
DCNL5. By contrast, UBE2FNAc protein preferentially binds
DCNL3P with a Kd of 1 mM, with a 5-fold decrease in binding
to DCNL1P and DCNL2P, and Kd values for binding to DCNL4
P
and DCNL5P were too high for us to measure. We could not
measure binding between unacetylated UBE2F and any of the
DCNLPONYdomains. Thus, N-terminal acetylation is a common
component of NEDD8 E2 interactions with DCNL family
members.
To understand the functional consequences of different DCNL
affinities for distinct cullins andNEDD8 E2s, we examined activa-
tion of NEDD8 transfer from UBC12NAc and UBE2FNAc to
different CULCTD-RBX complexes. All five DCNL PONY domainsreserved
Figure 2. Human DCNL PONY Domain
Interactions with Different Cullins and
N-terminally Acetylated NEDD8 E2s
(A) Thermodynamic parameters determined by
ITC for binding between the indicated human
DCNL PONY domains and cullin WHB sub-
domains.
(B) Previously published structure of CUL1WHB
(green) - DCNL1P(salmon) (PDB ID code 3TDU;
UBC12NAc peptide not shown) complex (Scott
et al., 2011) and model of CUL5WHB (olive) (Duda
et al., 2008)- DCNL1P(salmon) (Scott et al., 2011),
highlighting DCNL-CUL interacting residues.
(C) Thermodynamic parameters determined by
ITC for binding between the indicated human
DCNL PONY domains and unacetylated and
N-terminally acetylated versions of UBE2F, and an
N-terminally acetylated peptide corresponding to
UBC12.
See also Figure S2.
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CTD-RBX1 complexes (Figure 3A). Even in the presence of
a DCNL PONY domain, however, UBC12’s specificity for RBX1
was retained, as NEDD8 was not ligated to CUL5CTD in complex
with its native RBX partner, RBX2. Furthermore, all five DCNL
PONY domains also could stimulate NEDD8 transfer from
UBE2FNAc, as observed for CUL2CTD in complex with RBX1
and CUL5CTD in complex with either RBX1 or RBX2.
However, under the conditions of our assays, the different
DCNL/cullin/NEDD8 E2 combinations displayed great variation
in overall neddylation efficiencies, which generally correlate
with a combination of DCNL-independent activity and the
DCNLP-cullin and DCNLP-E2 interaction affinities (Figure 3).
For example, in accordancewith DCNLP-E2 interaction affinities,Structure 21, 42–53, January 8, 201DCNL1P and DCNL2P generally most
potently stimulate NEDD8 transfer from
UBC12NAc, DCNL3P generally most
potently stimulates NEDD8 transfer from
UBE2FNAc, and DCNL4P and DCNL5P
are generally less active toward both
E2s (Figures 2 and 3). Similarly, the very
high affinity interactions for all five DCNLs
with the CUL5WHB, taken together with
relatively high basal DCNL-independent
neddylation activity, explain the high level
of UBE2FNAc-mediated NEDD8modifica-
tion of CUL5CTD-RBX2 in the presence of
all of the DCNL PONY domains. It is only
at very low protein concentrations that
the neddylation reaction is slowed to the
point at which DCNL3P promotes slightly
more NEDD8 ligation to CUL5CTD from
UBE2FNAc (Figure 3C). At the opposite
end of the spectrum, CUL3CTD-RBX1 and
CUL4ACTD-RBX1 are very efficiently ned-
dylated by UBC12NAc in the presence of
DCNL1P and DCNL2P, and the reactions
are generally inefficient with UBE2FNAc(Figures 3A and 3B). For CUL3, whose WHB binds with similar
affinities to all the DCNL PONY domains, neddylation efficiency
is largely determined by DCNLP-E2 interaction strength, with
PONY domains from DCNL1, 2, and 3 all activating UBE2FNAc,
with DCNL3P displaying the greatest effect on UBE2FNAc-medi-
ated CUL3CTD neddylation (Figure 3B). The DCNL3P-UBE2FNAc
specificity is particularly evident for CUL4A, likely in part to
enhanced affinity of CUL4A’s WHB for DCNL3P.
Peptide Inhibition of DCNL-Dependent
UBE2FNAc-Mediated NEDD8 Ligation
We next probed whether the specificity of DCNL-NEDD8 E2
interactions could be recapitulated with peptides. As with
DCNL1P binding to an N-terminally acetylated peptide from3 ª2013 Elsevier Ltd All rights reserved 45
Figure 3. Variations in DCNL PONY Domain Activation of NEDD8 Transfer from N-terminally Acetylated NEDD8 E2s to Different Cullin
C-terminal Domain/RBX Complexes
(A) As indicated in the schematic diagram, pulse-chase [32P]NEDD8 transfer from UBC12NAc (left) or UBE2FNAc (right) to the indicated cullin C-terminal domain-
RBX complexes in the absence or presence of the indicated DCNL PONY domain. For comparison, all reactions were carried out under the same conditions.
(B) Extended time courses from (A) for pulse-chase [32P]NEDD8 transfer from UBE2FNAc to either CUL3CTD-RBX1 or CUL4ACTD-RBX1 in the absence or
presence of the indicated DCNL PONY domain.
(C) Pulse-chase reactions with the indicated concentrations of various components, monitoring [32P]NEDD8 transfer from UBE2FNAc to CUL5CTD-RBX2 in the
absence or presence of the PONY domain from DCNL1 or DCNL3.
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Distinctive N-acetylation-Dependent NEDD8 CascadesUBC12 (Figure 2C), DCNL3P binds an N-terminally acetylated
peptide from UBE2F, and N-terminal acetylation strongly
increases UBE2F peptide binding to DCNL3P (Figure 4A). To
test whether a peptide could compete with a full-length
NEDD8 E2, we examined the effects of adding peptides to
NEDD8 ligation assays. CUL5CTD in complex with its natural
partner, RBX2, was used as the target for these experiments
because UBE2F has been shown to mediate NEDD8 ligation to
CUL5 in cells (Huang et al., 2009) and because multiple DCNL
proteins stimulate this reaction in vitro (Figures 3A and 3C).46 Structure 21, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rightsPeptides corresponding to both UBC12NAc and UBE2FNAc
inhibited DCNL1P-dependent activity (Figure 4B). The peptide
derived from UBC12NAc inhibited this reaction more potently,
reducing the level of neddylation to that observed in the absence
of DCNL stimulation. In agreement with the observed interaction
preferences measured by ITC, opposite specificity was
observed for DCNL3P, for which the peptide derived from
UBE2FNAc was a more effective inhibitor (Figures 2C, 4A, and
4B). N-terminal acetylation was absolutely required for the
UBE2F peptide-mediated inhibition. Furthermore, the peptidereserved
Figure 4. Peptide Inhibition of DCNL Activation of NEDD8 Ligation Depends on N-terminal Acetylation
(A) ITC data for interactions between DCNL3P and unacetylated or N-terminally acetylated peptides from UBE2F. Upper panels show raw power data
recorded during titration experiments, and lower panels show fits of standard binding equations after integration of the raw data, using Origin (v. 7.0) software
provided from MicroCal.
(B) Pulse-chase monitoring [32P]NEDD8 transfer from UBE2FNAc to CUL5CTD-RBX2 in the absence or presence of the PONY domain from DCNL1 or DCNL3,
and unacetylated or N-terminally acetylated peptides corresponding to UBC12 or UBE2F.
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none of the peptides influenced the basal level of neddylation
in the absence of a DCNL PONY domain. Thus, the DCNL-E2
preferences observed by binding and in vitro neddylation reac-
tions were recapitulated by short peptide inhibitors (Figure 4B).
Crystal Structures of DCNL2P-UBC12NAc Peptide and
DCNL3P-UBE2FNAc Peptide Complexes: A Common
Mode of DCNL PONY Domain Interactions with
N-terminally Acetylated NEDD8 E2s
Tobetter understandhow thedifferentDCNLco-E3s interactwith
the different NEDD8 E2s, we undertook a broad campaign to
obtain crystal structures of complexes with distinctive partners.
We were able to obtain crystals of a complex between DCNL2P
and a 12-residue peptide from UBC12NAc (referred to as
UBC12NAc1-12) that diffracted to 3.3 A˚ resolution (Figure 5A; Table
1; FigureS3) andof a complexbetweenDCNL3Panda25-residue
peptide from UBE2FNAc (referred to as UBE2FNAc1-25) that
diffracted to 2.4 A˚ resolution (Figure 5B; Table 1; Figure S3)
and determined their structures using molecular replacement
(see the Experimental Procedures). Upon comparison with a
prior DCNL1P-UBC12NAc1-15 complex (Scott et al., 2011), the
structures reveal a common mode of NEDD8 E2 interactions
with DCNL PONY domains, with average root-mean-square
deviations (rmsds) of 0.6 A˚ between DCNL1P-UBC12NAc1-15
and DCNL2P-UBC12NAc1-12 and of 1.4 A˚ between DCNL1P-
UBC12NAc1-15 and DCNL3P-UBE2FNAc1-25 (Figure 5C; Table S1).
As observed for previous PONY domain structures (Kurz et al.,
2008; Scott et al., 2010, 2011; Sethe Burgie et al., 2011; Yang
et al., 2007), DCNL2P andDCNL3P consist entirely of helices (Fig-
ure 5). The N-terminally acetylated peptides from both NEDD8
E2s also form helical structures. The interactions are anchoredStructure 21by the N-acetyl-methionine from a NEDD8 E2 docking in a
deep hydrophobic pocket at the center of the DCNL PONY fold.
The structures explain the general requirement of NEDD8 E2
N-terminal acetylation in binding to DCNL PONY domains, as
an N-terminal positive charge would block burial of N-acetyl-
methionine into the DCNL hydrophobic pocket (Figure 6). In
the DCNL2P-UBC12NAc1-12 and DCNL3P-UBE2FNAc1-25 struc-
tures, these interactions involve the methyl moiety of the acetyl
group from the E2 packing in a hydrophobic pocket consisting
of the a-carbon from DCNL2P Ala98/DCNL3P Thr123 and side
chains from DCNL2P Val102, Leu103, and Leu184 and DCNL3P
Val127, Leu128, and Leu211, respectively. The E2’s amide
makes a hydrogen bond to the backbone carbonyl of a Pro
conserved in both DCNL PONY domains (97 in DCNL2P and
122 in DCNL3P). Also, the Met side chain from UBC12NAc1-12
extends into a deep hydrophobic channel formed by side chains
from DCNL2P’s Ile86, Cys90, Pro97, Val102, Ile105, Ala106,
Ala111, Cys115, Phe117, and Phe164. The Met side chain
from UBE2FNAc1-25 is buried in the corresponding hydrophobic
groove formed by DCNL3P’s Met111, Cys115, Pro122, Val127,
Leu130, Ala131, Ala136, Cys140, Phe142, and Phe189. The
hydrophobic NEDD8 E2 residues at positions 2 (Ile in UBC12
and Leu in UBE2F) and 4 (Leu in both UBC12 and UBE2F) further
pack against their respective DCNL partners to seal the
N-acetyl-Met1 in place. The DCNL2P and DCNL3P residues
interacting with N-acetyl-Met correspond to those observed
previously from DCNL1P (Scott et al., 2011).
Identification of a DCNL Residue Influencing Selective
NEDD8 E2 Interactions
We inspected the crystal structures for possible clues as to the
basis for the observed preferences for the different DCNL family, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 47
Figure 5. Overall Conserved Mode of DCNL
PONY Domain Interactions with Acetylated
N-terminal Helices from NEDD8 E2s
(A) Cartoon representation of overall structure of
DCNL2 PONY domain (raspberry) complex with
peptide from UBC12NAc (teal) with N-acetyl-Met1,
Ile2, and Leu4 shown in sticks.
(B) Cartoon representation of overall structure of
DCNL3 PONY domain (brick) complex with
peptide from UBE2FNAc (lime) with N-acetyl-Met1,
Leu2, and Leu4 shown in sticks.
(C) Superposition of DCNL2P-UBC12NAc1-12 and
DCNL3P-UBE2FNAc1-25 crystal structures with
prior structure of DCNL1P (pink)-UBC12NAc1-15
(cyan) (PDB ID code 3TDU) (Scott et al., 2011).
See also Figure S3.
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conserved interactions, some DCNL residues are poised to
make limited contacts to residues downstream of the N terminus
from the helix of the interacting NEDD8 E2 (Figure 7A). Of note is
a residue that is hydrophobic in DCNL1P (Ile83) and DCNL2P
(Val83) but acidic in DCNL3P (Glu108). This is poised to dock in
a hydrophobic surface in UBC12NAc between the side chains
of Leu4, Leu7, and the aliphatic portion of the side chain from
Lys8. For DCNL3P, the aliphatic portion of Glu108 contacts
a hydrophobic surface from a slightly different arrangement of
side chains on UBE2FNAc, from Leu4, the aliphatic portion of
Lys7, and Leu8. To test for a role in specificity, we swapped
the Ile and Glu from DCNL1P and DCNL3P, respectively, and
assayed activation of NEDD8 transfer from UBC12NAc and
UBE2FNAc to the CUL2CTD-RBX1 complex (Figure 7B). CUL2
was chosen as a representative target for these experiments
because both DCNL1P and DCNL3P potently stimulate NEDD8
ligation from both E2s to CUL2 (Figure 3A). For both NEDD8
E2s, a Glu substitution in place of DCNL1P’s Ile83 reduces
activity. Thus, theGlu alone is not a positive determinant of spec-
ificity for UBE2FNAc. However, a DCNL3P mutant with Glu108
replaced by Ile is more active toward UBC12NAc and shows
similar activity as wild-type DCNL3P toward UBE2FNAc. Although
we do not know the extent to which UBC12NAc is repelled by
Glu108 or attracted by the Ile substitution in DCNL3P, the data
imply that DCNL PONY domain residues contacting portions of
NEDD8 E2s downstream of the N-acetyl-Met can influence
specificity.
DISCUSSION
Multiple DCNL proteins have been implicated in augmenting
NEDD8 ligation to multiple cullins in vivo (Huang et al., 2011;
Kim et al., 2008; Meyer-Schaller et al., 2009; Wu et al., 2011).
However, the relative biochemical potential and thermodynamic
preferences for different DCNL PONY domain, cullin WHB
subdomain, and NEDD8 E2 interactions have remained largely
uncharacterized. Here, we found that all PONY domains can
stimulate cullin neddylation from both E2s, with a wide-range48 Structure 21, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rightsof NEDD8 ligation efficiencies for different enzyme combinations
(Figure 3). In vitro NEDD8 ligation efficiency appears to be related
to a combination of the innately varying abilities of UBC12 and
UBE2F to mediate NEDD8 ligation to different RBX-CUL
complexes (Huang et al., 2009) and the wide range of DCNL
affinities for the different CUL WHB subdomains and NEDD8
E2s (Figures 2 and 3). Our data indicate that intrinsic RBX-E2
interaction specificity would dominate pathway establishment
in vivo because none of the DCNL PONY domains can overcome
the exclusion of UBC12-mediated NEDD8 ligation to CUL5CTD
associated with RBX2 (Figure 3). In vivo, overexpression of
UBE2F can compensate for knockdown of UBC12 and promote
NEDD8 ligation to CUL1 or CUL2, presumably in complex with
RBX1. However, UBE2F knockdown only leads to decreased
levels of neddylated CUL5, suggesting that endogenous
UBE2F function is restricted to RBX2 (Huang et al., 2009). This
specificity is likely a result of the relatively high-level expression
of UBC12, which would occupy RBX1, and low-level expression
of UBE2F combined with availability of RBX2 (Huang et al.,
2009). Thus, RBX2’s tolerance for UBE2F establishes NEDD8
E2 specificity for its only known endogenous cullin partner,
CUL5 in vivo (Huang et al., 2009; Kamura et al., 2004). CUL5’s
WHB subdomain binds all DCNL PONY domains with high
affinity (Figure 2), suggesting that multiple DCNL proteins could
contribute to CUL5 neddylation in cells. Although only the PONY
domains from DCNLs 1-3 show appreciable interaction with
UBE2FNAc, in the context of the multiple interaction surfaces
for DCNL/NEDD8 E2/RBX/CUL complexes, the effective con-
centrations of any individual component will be much higher,
which might overcome the low intrinsic affinities between
DCNL4 or DCNL5 and both NEDD8 E2s (Figures 2 and 3).
In a related vein, at least some fraction of DCNL-CUL interac-
tions are also not redundant, as lysates from HeLa cells after
siRNA-mediated knockdown of DCNL1 or DCNL3, or from null
MEFs or testes of DCNL1 knockout mice, showed reduced
levels of the NEDD8-ligated species for multiple cullins (Huang
et al., 2011; Kim et al., 2008; Meyer-Schaller et al., 2009).
Subcellular localization of neddylation enzymes can also be
regulated. For example, UBC12 is largely nuclear, and nuclearreserved
Table 1. Data Collection and Refinement Statistics
DCNL2P:
UBC12NAc1–12
DCNL3P:
UBE2FNAc1–25
PDB ID code 4GAO 4GBA
Data collection
Beamline APS 24-ID-E ALS 8.2.2
l 0.97915 0.97910
Space group P21 P21
Complexes in a.u. 4 2
Cell dimensions
a, b, c (A˚) 48.57, 190.15, 49.07 83.47, 44.58, 101.22
a, b, g () 90.00, 101.75, 90.00 90.00, 103.30, 90.00
Resolution (A˚) 3.3 2.4
Rmerge (%) 18.2 (44.9) 11.0 (47.4)
I/sI 6.2 (1.7) 15.4 (1.9)
Completeness (%) 98.9 (93.2) 99.7 (97.9)
Redundancy 3.2 (2.5) 1.9 (1.8)
Refinement
Resolution (A˚) 3.3 2.4
Reflections work
set/test set
11,723/643 27,346/1,466
Rwork/Rfree 25.2/29.6 19.1/23.0
No. atoms
Protein/ligand 6,027/270 3,277/159
Solvent 135
Bromides 2
B-factors (A˚2)
Protein+peptide 51.3 43.9
Solvent 43.7
Bromides 49.7
Wilson B (A˚2) 55.3 36.9
Rmsd
Bond lengths (A˚) 0.009 0.008
Bond angles () 0.951 1.032
Ramachandran (%)
Preferred regions 97.7 96.6
Allowed regions 2.3 3.4
Disallowed regions 0.0 0.0
Data for highest resolution shell is shown in parentheses.
Rwork =
PjFo  Fcj=
P
Fo. Rfree is the cross-validation of R-factor, with
5%–10% of the total reflections omitted in model refinement. See also
Table S1.
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Distinctive N-acetylation-Dependent NEDD8 Cascadeslocalization of DCNL1 is important for its role as a co-NEDD8 E3
(Huang et al., 2011; Wu et al., 2011). Besides the conserved
PONY domain, the DCNLs display a range of N-terminal
sequences, which can also influence localization (Meyer-Schal-
ler et al., 2009). Membrane localized DCNL3 apparently plays an
important role in NEDD8 ligation to CUL3 (Meyer-Schaller et al.,
2009). In addition to subcellular partitioning of the different
components of NEDD8 ligation pathways, it is also possible
that the distinct DCNL N-terminal regions could impart other
forms of regulation. Furthermore, different expression levels
may also influence whether the different DCNLs function asStructure 21co-E3s for NEDD8, as our data show that even in the absence
of any biological regulation, differences in interaction affinities
impact DCNL/NEDD8 E2/CUL partnering at various protein
concentrations (Figures 2 and 3). Differences in innate, DCNL-
independent neddylation efficiencies for CUL-RBX complexes
may also influence sensitivity to DCNL co-E3 activity. In this re-
gard, we note that the CUL3CTD-RBX1 complex shows the
lowest level of DCNL-independent neddylation under a range
of experimental conditions, with both acetylated and unacety-
lated UBC12 and UBE2F (Huang et al., 2009; Figure 3). Interest-
ingly, a single-point mutation in the DCNL PONY binding region
of the CUL3 WHB almost entirely eliminated neddylation of
HA-tagged CUL3 expressed in HeLa cells (Meyer-Schaller
et al., 2009). Given our data—that all DCNL PONY domains
can in principle interact with the WHB subdomains from cullins
1–5 (Figure 2)—future studies will be required to deconvolute
DCNL-CUL specificities in vivo, including spatiotemporal
regulation.
Our data revealed that N-terminal acetylation not only of
UBC12 but also of UBE2F is required for DCNL activa-
tion (Figures 1 and 3). With two structures described herein,
crystallographic analyses now show the detailedmolecular inter-
actions for the three highest affinity DCNL-NEDD8 E2
complexes: DCNL1P-UBC12NAc, DCNL2P-UBC12NAc, and
DCNL3P-UBE2FNAc. The structures reveal common mecha-
nisms by which DCNL-NEDD8 E2 complexes depend on acety-
lation: the acetyl group both neutralizes a positive charge at
a NEDD8 E2’s N terminus, which would obstruct the interaction,
and also makes positive interactions upon burial along with the
rest of the N-acetyl-Met in a deep pocket within a DCNL PONY
domain. Thus, the PONY domain joins a short list of known
acetylation-specific interaction modules. Comparing N-acetyl-
methionine recognition by PONY domains of the DCNL family
to acetyl-lysine recognition bymodules, such as bromodomains,
reveals a common feature: N-acetyl-methionine and acetyl-
lysine are both inserted into a hydrophobic pocket, in which it
would be unfavorable to bury the positive charge masked by
acetylation (Figure S4) (Dhalluin et al., 1999; Owen et al., 2000;
Sanchez and Zhou, 2009). Notably, recent development of
selective bromodomain inhibitors that occupy the hydrophobic
pocket and prevent acetyl-lysine binding (Filippakopoulos
et al., 2010; Nicodeme et al., 2010) raises the possibility that
N-acetyl-methionine binding sites may also be targeted by small
molecules. Analysis of the surface of the DCNL1P (Scott et al.,
2011), DCNL2P, and DCNL3P PONY domains with the program
CASTp (Dundas et al., 2006) indicates surface exposed pockets
of 347, 355, and 379 A˚3, respectively, when averaged over all
copies per asymmetric unit, which would seem plausible for
chemical targeting. This is of particular importance for DCNL1,
as the gene encoding human DCNL1, which is also called
‘‘SCCRO’’ for squamous cell carcinoma-related oncogene, is
amplified in the 3q26.3 region in squamous cell carcinoma
(SCC). Notably, DCNL1 amplification and overexpression in
SCC of mucosal origin is associated with adverse clinical
outcome (Estilo et al., 2003; Sarkaria et al., 2006). NIH 3T3 cell
lines overexpressing DCNL1 display many attributes associated
with transformation, including colony formation on soft agar and
oncogenicity in a xenograft assay in nude mice (Sarkaria et al.,
2006). Thus, the N-acetyl-methionine binding site in DCNL1, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 49
Figure 6. A DCNL Hydrophobic Pocket
Surrounds N-acetyl-methionine from a
NEDD8 E2
(A) Close-up view of DCNL2P-UBC12NAc1-12
structure, with DCNL2P surface colored by elec-
trostatic potential, and UBC12NAc1-12 shown in
cyan with N-acetyl-Met1, Ile2, and Leu4 shown in
sticks.
(B) Close-up view of DCNL3P-UBE2FNAc1-25
structure, with DCNL3P surface colored by elec-
trostatic potential, and UBE2FNAc1-25 shown in
cyanwith N-acetyl-Met1, Leu2, and Leu4 shown in
sticks.
See also Figure S4.
Structure
Distinctive N-acetylation-Dependent NEDD8 Cascadesmay be an attractive candidate for development of small mole-
cule therapeutics.
This raises the question of whether there is any specificity
among perhaps numerous protein-protein interactions depen-
dent on N-acetyl-Met. In some cases, the acetyl group has
been proposed to provide a hydrogen bond to establish
secondary structure required for protein-protein interactions,
without directly mediating contacts to partner proteins (Frye
et al., 2010; Greenfield et al., 1994). However, we anticipate
that there will be many cases like DCNL-NEDD8 E2 complexes,
in which the interaction is driven by direct contacts with the
N-acetyl-Met. In this regard, it is informative to compare the
highly homologous DCNL1-UBC12NAc, DCNL2-UBC12NAc, and
DCNL3-UBE2FNAc complexes. The structures not only reveal
subtle differences in the N-acetyl-Met binding pockets but also
differences in the constellation of amino acids contacting prox-
imal residues. This is particularly evident when comparing inter-
actions with the PONY domains from either DCNL1 or DCNL2,
which are 82% identical in sequence, to the more divergent
but still more than 40% identical PONY domain of DCNL3 (Table
S1; Figure 6). Encouragingly, we find that short N-terminal
peptides from UBC12NAc and UBE2FNAc display distinct prefer-
ences for inhibiting DCNL1P- or DCNL3P-activated NEDD8 liga-
tion, respectively (Figure 4B), and that a single-point mutation
can significantly enhance the activity of DCNL3P’s PONY domain
toward UBC12NAc to eliminate this specificity under our assay
conditions (Figure 7B). Thus, our results suggest the potential
for selective manipulation of N-acetyl-methionine-dependent
protein-protein interactions.
EXPERIMENTAL PROCEDURES
Mass Spectrometry
C-terminally tagged UBE2F was purified from NIH 3T3 and SF9 cells. Peptides
generated from ArgC digestion of sample proteins were desalted offline using
C18 stage tips. Peptides were eluted from the stage tip, dried down using
a speed vac, and resuspended in 10 ml 5% formic acid, 5% acetonitrile.
Peptide mixtures were separated by in-line reverse phase using an 18 cm X
150 mm (ID) column packed with C18 (MAGIC C18 5 mm particle, 200 A˚ pore50 Structure 21, 42–53, January 8, 2013 ª2013 Elsevier Ltd All rights reservedsize) using a 50min 8%–26%acetonitrile gradient.
MS/MS data was generated using an LTQ-Velos
mass spectrometer (Thermo Fisher Scientific,
Waltham, MA, USA), a data-dependent top10
instrument method, and zoom scan for MS1
assignments. Data was acquired using CID with
the normalized collision energy set to 35% withactivation times of 10 ms. MS/MS triggering thresholds were set to 2,000,
and a 30 s dynamic exclusion was used with an exclusion list size of 500.
Resultant MS/MS spectra were searched using Sequest against a concate-
nated forward and reverse human IPI database (v3.6). Methionine oxidation
(+15.99), acetylation (+42.01), and the combined modification (+58.09) were
set as dynamic modifications.
Intact protein mass spectra were obtained with reverse-phase liquid chro-
matography (RPLC)-desalted samples introduced by flow injection, using an
ion trap mass spectrometer (Bruker, Billerica, MA, USA).
Isothermal Titration Calorimetry
Measurements were performed using aMicroCal ITC200. For DCNLP:CULWHB
experiments, protein samples were buffer matched by desalting over a NAP-5
column (GE Healthcare, Waukesha, WI, USA) into 25 mM Tris, 100 mM NaCl,
and 1 mM BME (pH 7.6). DCNLP samples were placed in the sample cell at
a final concentration of 100 mM at 22C. The ligand, CULWHB (1 mM) was
constantly injected (2.5 ml). The interval time between each injection was
3 min, and the duration of each injection was 5 s. For DCNLP: UBC12NAc1-21
experiments, UBC12NAc1-21 was dissolved by weight to a final concentration
of 10 mM, and DCNLP samples were buffer matched in 50 mM HEPES,
125 mM NaCl, and 1 mM BME (pH 7.0). DCNLP was placed into the sample
cell at a final concentration of 400 mM at 12C. The ligand, UBC12NAc1-21
(4 mM) was constantly injected (1.5 ml). The interval time between each injec-
tion was 3min, and the duration of each injection was 3 s. For experiments with
UBE2FNAc, protein samples were buffer matched by desalting over a NAP-5
column into 25mMHEPES, 125mMNaCl, and 1mMBME (pH 7.0). UBE2FNAc
was placed into the sample cell at a final concentration of 100 mM at 16C. The
ligand, DCNLP (1 mM) was constantly injected (2.5 ml). The interval time
between each injection was 3 min, and the duration of each injection was
5 s. Obtained spectra were evaluated using Origin (v. 7.0) to determine heats
of binding andKd values. All ITC experiments were performed independently at
least two times, with similar results. Values from one experiment are
presented.
Crystallography
Crystals were grown by the hanging-drop vapor-diffusion method. Crystals of
DCNL2P–UBC12NAc1-12 were grown at 4C in 20% PEG2000 MME, 0.1 M
NaBr, 3% sorbitol in a 1:1 drop of protein:mother liquor. The crystals were
harvested from mother liquor supplemented with 30% of a 50:50 mixture of
glycerol:ethylene glycol prior to flash-freezing in liquid nitrogen. Reflection
data were collected at NECAT ID-24-E at the Advanced Photon Source. The
DCNL2P-UBC12NAc1-12 crystals diffracted weakly, and the diffraction spots
were not spherical in shape, resulting in a relatively high Rmerge. The data are
of similar quality for all resolution shells. Processing the data using different
Figure 7. Amino Acid Identity Downstream of N-acetyl-methionine Influences E2 Specificity of DCNL-Stimulated NEDD8 Ligation
(A) Close-up views of superimposed DCNL1P-UBC12NAc1-15 (Scott et al., 2011) and DCNL3P-UBE2FNAc1-25 crystal structures, highlighting interactions with
residues downstream of the N terminus.
(B) Pulse-chase assays monitoring [32P]NEDD8 transfer from UBC12NAc (top) or UBE2FNAc (lower) to CUL2CTD-RBX1 in the absence or presence of the wild-
type and indicated mutant versions of the PONY domains from DCNL1 and DCNL3.
Structure
Distinctive N-acetylation-Dependent NEDD8 Cascadesframe combinations, different spot and background sizes, and different
programs all gave similar results. The crystals belong to space group P21
with four DCNL2P–UBC12NAc1-12 complexes in the asymmetric unit. Crystals
of DCNL3P–UBE2FNAc1-25 were grown at 4C in 2.28 M sodium malonate
(pH 7.0) in a 2:1 drop of protein:mother liquor. The crystals grew as multiple
clusters. Single crystals of the complex were obtained by streak-seeding
into 2.05 M sodium malonate (pH 7.0). The crystals were harvested from
mother liquor supplemented with 30% glycerol prior to flash-freezing in liquid
nitrogen. Reflection data were collected at beamline 8.2.2 at the Advanced
Light Source. The DNCL3P–UBE2FNAc1-25 data included numerous ice
rings, which presumably contribute to the high Rmerge value. The crystals
belong to space group P21 with two DNCL3
P–UBE2FNAc1-25 complexes in
the asymmetric unit.
Data were processed with HKL2000 (Otwinowski and Minor, 1997). Phases
for both structures were obtained by molecular replacement (MR) using
PHASER (McCoy et al., 2007) using the following search models: for the
DCNL2P–UBC12NAc1-12 structure, four copies of chains A and F from the
Protein Data Bank (PDB) ID code 3TDU (Scott et al., 2011); for the DCNL3P–
UBE2FNAc1-25 structure, two copies of residues 93–269 from a DCNL3P model
generated by the Modweb server (Eswar et al., 2007; Sali and Blundell, 1993).
For the DCNL2P–UBC12NAc1-12 structure, the peptide was included in the MR.
Thus, simulated annealing (SA) composite omit maps were used throughout
model building stages to reducemodel bias during subsequent fitting. The final
model contains only peptide residues and/or their associated side chains
present in the SA Fo-Fc omit maps at 2.5s. For DCNL3P–UBE2FNAc1-25, the
peptide was built manually, and general manual rebuilding was performed
with COOT (Emsley and Cowtan, 2004). Refinement was performed using
Phenix (Adams et al., 2010) and Refmac (Murshudov et al., 1997). For the
DCNL2P-UBC12NAc1-12 complex, medium 2-fold NCS restraints were used:
DCNL2P protomers A with D, and B with G. Peptides were not included in
NCS restraints. Details of refinement are provided in Table 1.
Biochemical Assays
DCNLP-mediated co-E3 activity wasmonitored using pulse-chase assays. For
the ‘‘pulse,’’ 10 mMof the indicated versions of UBC12 or UBE2Fwere charged
with [32P]-NEDD8, for 15 min at room temperature using 0.1 mM E1 and 15 mM
[32P]-NEDD8 in 50mMHEPES, 100mMNaCl, 1.5mMATP, and 2.5mMMgCl2
(pH 7.5). Formation of an E2[32P]-NEDD8 intermediate was quenched with
50 mM EDTA on ice for 5 min. Other than in Figure 3C, where additional details
are provided, chase reactions involved dilution of the E2[32P]-NEDD8 thio-
ester conjugate to 40 nM in 100 mM Tris, 100 mM NaCl, 50 mM EDTA, and
0.5 mg/ml BSA (pH 6.8). Chase reactions were initiated at 0C by the additionStructure 21of 125 nM CULCTD-RBX with or without 500 nM DCNLP. Aliquots were
removed at the indicated times and quenched with 2X SDS-PAGE sample
buffer. Reaction products were heated at 70C for 1 min and separated on
4%–12% NuPAGE gels (Invitrogen, Carlsbad, CA, USA). Dried gels were
exposed to a Storm (GE) Phosphoimager screen.
For peptide inhibition experiments, pulse-chase assays were performed as
described above in the absence or presence of 300 mM unacetylated or acet-
ylated UBC12 or UBE2F peptides.
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